Please assess the completion status of the following clinical trial:

Trial Title: Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with confirmed active malignancy AND,~* Presence of at least moderate (\>10cm) pericardial effusion on CT or Echocardiography~Exclusion Criteria:~* Patients unable to give an informed consent,~* Previous history of open-heart surgery~* Previous history of pericardial window or pericardial instillation of sclerosing therapy.~* Scheduled thoracic or cardiac surgery within the next 3 months~* Patients with contraindications for endovascular procedure such as disseminated intravascular coagulopathy or significant ongoing bleeding tendency, and systemic septicaemia.~* Patient with small or loculated pericardial effusion that is not accessible by subxiphoid approach.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (pericardiotomy) (Type: EXPERIMENTAL): * Patient in this arm will receive balloon pericardiotomy before insertion of pericardiocentesis.~* An 20mm over-the-wire ultra-non-compliant Percutaneous Transluminal Angioplasty Balloon is used to dilate the pericardium.~* Success of balloon pericardiotomy is confirmed by full inflation of the balloon which is confirmed on two orthogonal projections.~* Standard pericardiocentesis with prolonged drainage is performed afterwards.~* Pericardial drain is removed when output is less than 100cc/day
- Control (standard pericardiocentesis) (Type: NO_INTERVENTION): * Standard pericardiocentesis procedure is performed using standard pigtail pericardial drain. - Pericardial fluid is then tapped until dry on table.~* Pericardial drain is removed when output is less than 100cc/day

Based on this trial design, predict the completion outcome and termination type (if applicable).